Northern Trust
CLRB icon

Northern Trust’s Cellectar Biosciences CLRB Stock Holding History

Northern Trust’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,600
Closed -$24.6K – 4423
2025
Q1 		$24.6K Hold
2,600
– – ﹤0.01% 4318
2024
Q4 		$23.3K Buy
2,600
+564
+28% +$26.1K ﹤0.01% 4362
2024
Q3 		$131K Hold
2,036
– – ﹤0.01% 3992
2024
Q2 		$153K Buy
2,036
+291
+17% +$27.9K ﹤0.01% 3943
2024
Q1 		$208K Buy
1,745
+1,322
+313% +$143K ﹤0.01% 3884
2023
Q4 		$35.1K Buy
+423
New +$31.5K ﹤0.01% 4295
2022
Q3 		– Sell
-318
Closed -$39K – 4722
2022
Q2 		$39K Hold
318
– – ﹤0.01% 4474
2022
Q1 		$66K Hold
318
– – ﹤0.01% 4465
2021
Q4 		$63K Hold
318
– – ﹤0.01% 4546
2021
Q3 		$88K Hold
318
– – ﹤0.01% 4433
2021
Q2 		$114K Hold
318
– – ﹤0.01% 4332
2021
Q1 		$154K Buy
318
+170
+115% +$101K ﹤0.01% 4178
2020
Q4 		$92K Buy
148
+64
+76% +$29.4K ﹤0.01% 4131
2020
Q3 		$31K Buy
+84
New +$33.2K ﹤0.01% 4154
2018
Q3 		– Sell
-10
Closed -$18K – 4314
2018
Q2 		$18K Hold
10
– – ﹤0.01% 4222
2018
Q1 		$33K Buy
10
+3
+43% +$10.7K ﹤0.01% 4123
2017
Q4 		$27K Buy
7
+2
+40% +$8.94K ﹤0.01% 4131
2017
Q3 		$28K Hold
5
– – ﹤0.01% 4121
2017
Q2 		$27K Hold
5
– – ﹤0.01% 4152
2017
Q1 		$37K Buy
+5
New +$29.7K ﹤0.01% 4087

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Northern Trust's CLRB Position: Q2 2025 in Review

Northern Trust sold out of Cellectar Biosciences (CLRB) in Q2 2025, closing a stake of 2,600 shares — an estimated $24.6K sold.

Northern Trust first reported a position in CLRB in Q1 2017 and held it in 20 quarters. The position peaked at $208K in Q1 2024. 19 funds tracked by Wall St. Rank hold CLRB as of Q2 2025.

  • Northern Trust reported no remaining Cellectar Biosciences position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 2,600 Cellectar Biosciences shares in Q2 2025, an estimated $24.6K.
  • Northern Trust first reported a position in Cellectar Biosciences in Q1 2017 and held it in 20 quarters.
  • Northern Trust's Cellectar Biosciences position peaked at $208K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.